SAAKSHI — Saakshi Medtech and Panels Income Statement
0.000.00%
- IN₹2.52bn
- IN₹2.70bn
- IN₹1.22bn
- 27
- 33
- 14
- 11
Annual income statement for Saakshi Medtech and Panels, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 598 | 916 | 1,221 | 1,219 |
Cost of Revenue | ||||
Gross Profit | 186 | 309 | 422 | 432 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 556 | 777 | 1,042 | 1,060 |
Operating Profit | 41.8 | 138 | 179 | 158 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 31.5 | 126 | 166 | 149 |
Provision for Income Taxes | ||||
Net Income After Taxes | 22 | 93.8 | 124 | 113 |
Net Income Before Extraordinary Items | ||||
Net Income | 22 | 93.8 | 124 | 113 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 22 | 93.8 | 124 | 113 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 1.24 | 5.3 | 7.01 | 6.4 |